<DOC>
	<DOCNO>NCT03105505</DOCNO>
	<brief_summary>The study aim investigate effect Permethrin 5 % treatment Signs symptoms Demodex-blepharitis comparison Synthomycine 5 % Fucithalmic ( fusidic acid 1 % ) .</brief_summary>
	<brief_title>Prospective-Randomized Trial Assessing Efficacy Permethrin 5 % Demodex - Blepharitis Treatment Comparison Fucithalmic ( Fusidic Acid 1 % ) Synthomycine 5 %</brief_title>
	<detailed_description>3 arm study . 75 patient total , 25 patient group . Group A ( study group ) patient apply facially Permethrin 5 % every night 3 month . Group B patient apply eyelid Fusidic acid 1 % every night 3 month . Group C patient apply eyelids Synthomycine 5 % every night 3 month Follow Evaluation make one week , one month , two month , three month , 4 month half year .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Blepharitis</mesh_term>
	<mesh_term>Permethrin</mesh_term>
	<mesh_term>Fusidic Acid</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<criteria>Adult ( Age â‰¥18Y ) individual clinically diagnose Demodex blepharitis . Known sensitivity study medication component . Pregnant woman individual deem unfit provide inform consent . Systemic steroid use .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>